Lv1
40 积分 2021-03-03 加入
Overcoming solid-tumor barriers: armored CAR-T cell therapy
5天前
已完结
Parallel 4-1BB Signaling in Dual DLL3/CD56-Targeting CAR-T Cells Triggers Adaptive Proliferation and Functional Persistence to Eradicate Small Cell Lung Cancer
9天前
已完结
P1.11.67 VEGFR1/PD-L1 CAR-T Cell Treatment of Solid Tumor-Derived Malignant Pleural Effusion/Ascites
12天前
已完结
Strategies of AI‐Driven CAR‐T Cell Therapy Towards Solid Tumours
15天前
已完结
Chimeric Antigen Receptor T-Cell Therapies: Barriers and Solutions to Access
20天前
已完结
Bioengineering CAR-T cells to function in hostile tumor microenvironments
22天前
已完结
Common gamma chain cytokines-driven optimization of chimeric antigen receptor T cells: Mechanistic insights and future directions
24天前
已完结
Optimal avidity of the Immune Synapse and mitochondrial repair trigger asymmetrical cell division and CAR T cell persistence - Review
1个月前
已完结
Multi-dimensional orchestration of binders for improved CAR-T immunotherapy
1个月前
已完结
Coengineering specificity, safety, and function into T cells for cancer immunotherapy
1个月前
已完结
皖公网安备34019202002308
